Generium Pharmaceutical News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Serbia produces first series of Sputnik V vaccine Serbia produces first series of Sputnik V vaccine Belgrade, Apr 15 (Prensa Latina) The first series of the Russian Sputnik V vaccine against Covid-19, in control doses, was produced Wednesday at Torlak Institute of Virology, Vaccines and Serums, as announced by Nenad Popovic, Serbian Government's Non-Portfolio minister in charge of Innovation and Technological Development. Popovic remarked that this new Sputnik V series was carried out under supervision of specialists from Russia´s Fund for Direct Investment and Generium Pharmaceutical Compan...

The St Kitts Nevis Observer (CNN)- Russia’s Sputnik V has seen rising popularity across Latin America as more countries announce shipments and deals to purchase the Covid-19 vaccine. Nine Latin American countries so far have approved usage of the Sputnik V vaccine — Argentina, Bolivia, Guatemala, Guyana, Honduras, Mexico, Nicaragua, Paraguay and Venezuela. Distribution of the vaccine has also begun in Argentina, Bolivia, Mexico, Nicaragua, Paraguay and Venezuela. The vaccine has been approved in 39 countries around the world, according to the Russian Direct Investment Fund (RDIF), which...

Photo courtesy: CNN (CNN) -- Decades ago, Soviet scientists researched biological weapons at a site in Volginsky, about 70 miles east of Moscow. Now, that site is being used to mass-produce a vaccine aimed at protecting people around the world from the coronavirus. CNN gained exclusive access to the facility, now home to Generium Pharmaceutical, which has been contracted to scale up production of the Russian vaccine against COVID-19, Sputnik V. The vast high-tech complex is one of seven new production centers across the country. Every step in the production process had to be carefully design...

Russia shows off new Covid-19 vaccine factory even as its people hesitate to get the shot Decades ago, Soviet scientists researched biological weapons at a site in Volginsky, about 70 miles east of Moscow. Now, that site is being used to mass-produce a vaccine aimed at protecting people around the world from the coronavirus. CNN gained exclusive access to the facility, now home to Generium Pharmaceutical, which has been contracted to scale up production of the Russian vaccine against Covid-19, Sputnik V. The vast high-tech complex is one of seven new production centers across the country. Eve...